LETROZOLE / FEMARA MEDICATION PATIENT INFORMATION IN RUSSIAN

Фемара снижает количество эстрогена, блокируя фермент («ароматазу»), участвующий в производстве эстрогенов, и, следовательно, может блокировать рост рака молочной железы, для роста которого необходимы эстрогены.

Source: https://shorturl.at/jlHT5

#ЛетрозолИнструкция #Фемара #ЛечениеРака #ЖенскоЗдоровье #ПрепаратыОтРака #ЖенскоеЗдоровье #МедицинскаяИнформация #ЛечениеРакаМолочнойЖелезы #Онкология #ЗдоровьеЖенщин #РакМолочнойЖелезы

LETROZOLE / FEMARA MEDICATION PATIENT INFORMATION IN DUTCH

Femara bevat de werkzame stof letrozol. Het behoort tot een groep geneesmiddelen die aromataseremmers worden genoemd. Het is een hormonale (of "endocriene") behandeling van borstkanker.

Source: https://shorturl.at/gxDU9

#LetrozoleInformatie
#FemaraMedicatie
#HormoontherapieNL
#BorstkankerBehandeling
#LetrozoleBijwerkingen
#FemaraGebruik
#HormoontherapieAdvies
#BorstkankerSteun
#LetrozoleDosering
#FemaraPatiënteninfo

LETROZOLE / FEMARA MEDICATION PATIENT INFORMATION IN FILIPINO

Ang Femara ay naglalaman ng isang aktibong sangkap na tinatawag na letrozole. Ito ay kabilang sa isang pangkat ng mga gamot na tinatawag naaromatase inhibitors.Ito ay isang hormonal (o "endocrine") na paggamot sa kanser sa suso.

Source: https://shorturl.at/oxEFO

#LetrozolePH
#FemaraPilipinas
#HealthPH
#breastcancerawareness
#InfoMedikalFilipino

LETROZOLE / FEMARA MEDICATION PATIENT INFORMATION IN SWEDISH

Femara minskar mängden östrogen genom att blockera ett enzym ("aromatas") som är involverat i produktionen av östrogener och kan därför blockera tillväxten av bröstcancer som behöver östrogener för attväxa.

Source: https://shorturl.at/fnuFJ

#LetrozoleInformation #FemaraInformation #PatientEducation #SwedishMedication #HealthcareSweden #MedicationGuide #LetrozoleSweden #FemaraSweden #SwedishHealthcare #cancertreatment #breastcancerawareness #SwedishPatientResources

LEVOSIMENDAN / SIMDAX MEDICATION PATIENT INFORMATION IN KOREAN

Levosimendan은 독특한 작용 방식을 가진 수축성 작용제입니다. 칼슘에 대한 심근의 민감 도를 높여 심장 수축력을 높이는 칼슘 증감제입니다. 결과적으로 레보시멘단은 베타 수용체 또는 순환 AMP와 무관한 긍정적인 수축 효과를 나타냅니다.

Source: https://shorturl.at/bdsvX

#레보시멘단
#시마다스
#심장약
#한국어약물정보
#의료정보
#환자안내
#의료정보번역
#의약품정보
#한글약물정보
#한글환자안내

NELFINAVIR / VIRACEPT MEDICATION PATIENT INFORMATION IN TURKISH

Nelfinavir, insan immün yetmezlik virüsü (HIV) enfeksiyonunu tedavi etmek için diğer ilaçlarla birlikte kullanılır. Nelfinavir, proteaz inhibitörleri adı verilen bir ilaç sınıfındadır. Kandaki HIV miktarını azaltarak çalışır.

Content Source: https://shorturl.at/oxDMV

#Nelfinavir #Viracept #HIVtedavisi #HIVilaçları #TedaviBilgisi #Sağlık #AIDSbilgisi #TIP #HIVfarkındalık #NelfinavirBilgisi #ViraceptTedavisi #TürkçeSağlık #HIVtedavisiTürkçe #AIDSbilgisiTürkçe #ViraceptHakkında #NelfinavirNedir #ViraceptNasılKullanılır #HIVtedavisiNasılYapılır

Raltegravir / Isentress Medication Patient Information In #russian

Ралтегравир используется вместе с другими лекарствами для лечения инфекции, вызванной вирусом иммунодефицита
человека (ВИЧ), у взрослых и детей с массой тела не менее 4,5 фунтов (2 кг).

Source: https://shorturl.at/ckNO7

#Ралтегравир
#Исентресс
#Медикаментация
#Пациенты
#Лечение
#Информация
#Русский
#Здоровье
#Фармакология
#Препарат
#Советы
#Безопасность
#Дозировка
#Побочныеэффекты
#Инструкция
#Фармацевтика
#Пациентскаязабота
#Здоровыйобразжизни
#Лекарство
#Информированность
#Медицина

Evolving role of zoledronic acid in early breast cancer

Most women diagnosed in the early stages of breast cancer are likely to have a great prognosis. It is also likely that they remain disease free for several years after their treatment ends.

However, the side effects of such treatments associated with bone issues are also likely to have effect the patient's bone health in the long run.

The bone loss associated with breast cancer therapy like endocrine therapy may contribute towards the risk of osteoporosis and bone fractures in the long run.

Several guidelines for treatment are now changed to include the need for preserving bone health in adjuvant therapy regimes and any measures involved.

Source: https://shorturl.at/gnZ68

#BreastCancer
#ZoledronicAcid
#cancertreatment
#MedicalAdvancements
#bonehealth

Rare side effects study of Brigatinib

In 2017, FDA approved a next generation ALK inhibitor Brigatinib (Brand name ALUNBRIG, Ariad) as a second-line therapy after the treatment from crizotinib (Brand name XALHORI, Pfizer) for ALK+ NSLC (non-small lung cancer).

Brigatinib tablets are generally available in 30mg , 90mg and 180mg.

Source: https://shorturl.at/izMW6

#Brigatinib #RareSideEffects #SideEffectStudy #medicalresearch #rarediseases #HealthCare #Pharmacology #medicalscience #DrugSafety #BrigatinibStudy #HealthScience

The Effectiveness of Brigatinib over Crizotinib for Treating Non-Small Cell Lung Cancer

Brigatinib / Alunbrig is a cancer medication belonging to the class of anaplastic lymphoma kinase inhibitor or ALK. It has been proven to be efficient in treating non-small cell lung cancer or NSCLC that is ALK positive.

The ALK gene occurs in only 3-5 % of the patients of NSCLC. Crizotinib (also a first generation ALK inhibitor) showed a longer progression-free survival when compared to platinum based double agent chemotherapy medication.

Source: https://shorturl.at/bilG6

#BrigatinibSuccess #NSCLC #LungCancerTreatment #BrigatinibVsCrizotinib #MedicalAdvancements #cancerresearch #TargetedTherapy #PrecisionMedicine #lungcancerawareness #fightagainstcancer #TreatmentBreakthroughs #HealthcareInnovation #SurvivorStories #PersonalizedMedicine #clinicaltrials #BetterOutcomes #ImprovingSurvivalRates #InnovativeMedicine #ProgressInOncology #MedicalBreakthroughs #HopeForPatients #NSCLCTreatment

Palbociclib Improves Survival in Women with Breast Cancer

Palbociclib (Brand Ibrance) is a targeted therapy (CDK 4/6 inhibitor) manufactured by Pfizer which is used for the treatment of HER2-negative and HR-positive breast cancer. Ibrance is marketed by Pfizer in India under the Brand name of PALBACE.

Source: https://shorturl.at/rxJV7

#Palbociclib #BreastCancer #cancertreatment #SurvivalRates #medicalresearch #HealthCare #Oncology #WomenHealth #CancerTherapy #clinicaltrials

Approval of Lenvatinib as a therapy medication for Advanced Kidney Cancer

Lenvima is classified under the category of targeted therapy. The main aim for the medication which comes under this category is to target something specific to the cancer cells.

Lenvatinib commonly known as Lenvima (manufactured by Eisai), was approved by US Food and Drug Administration in 2016 for the treatment of advanced kidney cancer. This medication has been approved solely for the patients whose cancer has progressed even after receiving treatment from medications which blocks the tumour growth.

Source: https://shorturl.at/dekrZ

#AdvancedKidneyCancer
#KidneyCancerTreatment
#LenvatinibApproved
#NewHopeForRCC
#CancerResearchMatters
#ClinicalTrialsWork
#Lenvatinib #RCC
#TargetedTherapy
#MultikinaseInhibitor
#ProgressionFreeSurvival
#KidneyCancerCommunity
#RCCStrong
#NeverGiveUp
#YouAreNotAlone
#cancerfighter

Gastric Cancer Treatment with Docetaxel

Chemotherapy drugs kills the cancer cells depends upon their ability on how fast they halt the division of cells.
Docetaxel medication's main function is to damage the DNA or RNA cells which copy itself in the division.
With this drug working, cancer cells are not able to divide, thus leading to death of these cells.
Antimicrotubule agents like Docetaxel (Brand Taxotere) inhibits the microtubule structures within cells.
These microtubules plays a major role in replicating and dividing of cells, and docetaxel results in the untimely death of these cells.

Source: https://shorturl.at/gowDT

#GastricCancer #Docetaxel #cancertreatment #Chemotherapy #CancerTherapy
#medicaltreatment #Oncology #cancerresearch #HealthCare #GastricHealth
#GastricCancerAwareness #cancerfight #cancersurvivor #treatmentoptions
#CancerAwareness #cancercare #beatcancer

Can Entecavir lower the risk of Hepatocellular carcinoma in Hepatitis C patients

Entecavir (Brand Baraclude) along with another medication Tenofovir (Brand Telura, Vired) are the most commonly prescribed anti-viral medications for the first-line treatment of Hepatitis C virus.

Source: https://shorturl.at/eNV02

#Entecavir
#hepatitisc
#HepatocellularCarcinoma
#LiverCancer
#AntiviralTreatment
#liverhealth
#cancerprevention
#HealthCare
#treatmentoptions
#medicalresearch

Hepatitis B treatment with Entecavir

Baraclude is a reverse transcript inhibitor whose main function is to prevent the hepatitis B virus from multiplying, thus reducing the hepatitis B virus in the body.
Although entecavir reduces the hepatitis B virus, but it is not a cure for the disease.
Entecavir doesn't prevent liver damage or reduces the risk of developing liver cancer.

Source: https://shorturl.at/dvK38

#HepatitisB #Entecavir #Treatment #liverhealth #Medication
#viralinfection #AntiviralTherapy #hbv #HepB #liverdisease
#medicaltreatment #HealthCare #InfectiousDisease #Pharmaceuticals #AntiviralMedication

Improved Progression-Free-Survival in Renal Cell Cancer with Everolimus Treatment

Renal Cell Cancer or Renal Cell Carcinoma or RCC is the most common form of kidney cancer that is diagnosed in adults. RCC is fast growing and can often spread from the kidney to nearby organs.

The kidneys help in getting rid of waste and regulating fluid balance through tiny tubes known as tubules. RCC forms when the abnormal cancer cells start growing rapidly in the lining of tubules.

Learn More: https://shorturl.at/yDES7

#RenalCellCancer
#Everolimus
#cancertreatment
#ProgressionFreeSurvival
#ImprovedOutcomes
#RenalCancerAwareness
#fightcancer
#cancerresearch
#MedicalBreakthrough
#SurviveAndThrive
#Cancer
#KIDNEY #kidneydisease #kidneyhealth #kidneydiseaseawareness #kidneydiseasewarrior

Breast cancer treatment by Everolimus Therapy

Everolimus along with exemestane was approved for treating HER2 negative and HR-positive metastatic breast cancer after anastrozole or letrozole treatment had not shown successful. The results of this study showed that progression free survival was 4 months more for everolimus + exemestane treatment. The median PFS for exemestane + placebo group was 2.8 months as compares to everolimus + exemestane's 6.9 months.

Source: https://shorturl.at/fmCJ7

#EverolimusTherapy #BreastCancerTreatment #cancerresearch #MedicalInnovation #HealthcareAdvances #fightagainstcancer #WomenHealth #MedicalBreakthrough #Oncology #treatmentoptions #CancerTherapy

Sorafenib - Mechanism of Action in treating Advanced Hepatocellular Carcinoma

Sorafenib / Nexavar is approved by the FDA for the treatment of renal cell carcinoma. As a result of recent trials in treating solid tumours like HCC.

Sorafenib when combined with the conventional transarterial chemoembolization improved time for progression, tumour response rate and progression-free survival when compared to treatment with Sorafenib alone.

Source: https://shorturl.at/fmBCU

#Sorafenib
#HepatocellularCarcinoma
#LiverCancer
#cancertreatment
#TargetedTherapy
#MechanismOfAction
#AntiAngiogenesis
#MultikinaseInhibitor
#TyrosineKinaseInhibitor
#AdvancedCancer
#PrecisionMedicine
#Oncology
#medicalresearch

Survival Improvements in Ovarian Cancer by using Sorafenib

According to a new study, topotecan and Nexavar (generic Sorafenib) when combined, and there after used as a maintenance therapy has significantly improve the survival outcomes in women who are suffering from platinum-resistant ovarian cancer.

Source: https://shorturl.at/eiCDL

#OvarianCancerSurvival
#SorafenibTreatment
#cancerresearch
#SurvivalImprovements
#ovariancancerawareness
#MedicalAdvancements
#TreatmentInnovation
#fightagainstcancer
#HealthcareBreakthroughs
#cancersurvivor

Is Lupron Depot effective in the treatment of Prostate Cancer?

Leuprorelin / Leuprolide acetate works by getting a small implant injection of Lupron under the skin.
This therapy reduces the level of testosterone level in the human body by blocking LHRH production.

See Full Article: https://shorturl.at/itBVW

#LupronDepot #ProstateCancerTreatment #cancerresearch #MedicalAdvancements #LupronEfficacy #CancerTherapy #HealthcareInnovations #CancerAwareness #treatmentoptions #men 'sHealth #medicalscience

Votrient – Treatment for Renal Cell Cancer and Soft Tissue Sarcoma

Renal Cell Cancer (RCC) is one of the type of Kidney Cancer which affects the inner lining of the kidney.
Renal cancer is generally seen in adult men aged between 50 to 60 years.
This type of disease can easily spread to to Lungs and other organs of the body.

See Full Article: https://shorturl.at/duDP3

#Votrient
#RenalCellCancer
#SoftTissueSarcoma
#cancertreatment
#Oncology
#TargetedTherapy
#kidneycancer
#SarcomaAwareness
#medicaltreatment
#cancersupport
#HealthCare
#cancerresearch
#PatientCare
#TherapeuticOptions
#DrugTherapy
#CancerAwareness
#treatmentoptions
#OncologyCare
#ClinicalTrial
#DiseaseManagement

How Imatinib (Gleevec) Transformed Leukemia Treatment and Cancer Research

Gleevec (Imatinib) was developed with primarily with the help of researches conducted by National Cancer Institute (NCI), and Imatinib was one of the discoveries they made. This Drug has drastically improved the outcomes of patients who were suffering from Blood Cancer primarily Chronic Myelogenous Leukaemia. And due to the discoveries made by NCI that lead to Imatinib, they helped to establish a Targeted Therapy which had revolutionised the field of Cancer Research.

See full Article: https://shorturl.at/tyIL7

#Imatinib #Gleevec #LeukemiaTreatment #cancerresearch #MedicalBreakthrough
#TargetedTherapy #fightagainstcancer #InnovationInMedicine #HopeForPatients #TransformativeTreatment #ResearchAdvancements
#LifeSavingMedication #HealthCareHeroes #ScienceProgress #CancerAwareness #MedicalInnovation

How is Goserelin used for the treatment of Breast Cancer?

Goserelin (Brand Zoladex) is a medication used for treating Breast Cancer. It is a hormonal therapy drug that is given as an injection by a doctor or a nurse in a hospital setting or a clinic.

See Full Article: https://rb.gy/dbpv27

#GoserelinBreastCancerTreatment
#BreastCancerTherapyWithGoserelin
#GoserelinForBreastCancerCare
#GoserelinInBreastCancerManagement
#BreastCancerTreatmentOptionsGoserelin
#GoserelinTherapeuticApproachBreastCancer
#GoserelinProtocolBreastCancer
#GoserelinMedicationForBreastCancer
#GoserelinRoleInBreastCancerTherapy
#BreastCancerSupportWithGoserelin

The Effects of Gefitinib in EGFR Mutation Breast Cancer

Researchers have explored this treatment concept that iressa / gefitinib in combination with fulvestrant (an estrogen receptor antagonist) can have a positive impact on the hormonal therapy's anti-tumour effect.

Source: https://shorturl.at/bcsvH

#Gefitinib
#BreastCancer
#cancertreatment
#TargetedTherapy
#EGFRInhibitor
#cancerresearch
#Oncology
#HealthCare
#medicalscience
#SurvivorStories
#breastcancerawareness
#fightagainstcancer
#HopeForACure
#treatmentoptions
#PrecisionMedicine
#ChemotherapyAlternative
#TherapeuticAdvancements
#clinicaltrials
#SupportiveCare
#empowerment

The Role of Gefitinib in Treating Non-Small Cell Lung Cancer and Mutated Lung Cancer

Non-small Cell Lung Cancer (NSCLC) is the most common type of lung cancer.
And in only 10% of the cases, EGFR mutations are observed.
And gefitinib is generally recommended to people who have the most common type of EGFR mutations.

See More: https://shorturl.at/vKR12

#Gefitinib #NSCLC #LungCancerTreatment #MutatedLungCancer #TargetedTherapy #PrecisionMedicine #cancerresearch #Oncology #PersonalizedMedicine #MedicalAdvancements

The Connection Between Erlotinib Tarceva and Pancreatic Cancer

In combination with another medication Gemcitabine, Tarceva (Erlotinib) is used for treating patients who have been diagnosed with advanced stage pancreatic cancer.

Source: https://shorturl.at/xDY26

#Erlotinib
#Tarceva
#PancreaticCancer
#cancertreatment
#TargetedTherapy
#EGFRInhibitors
#PrecisionMedicine
#Oncology
#cancerresearch
#medicalscience

Erlotinib Tarceva Medication: Dosage, Uses, Side Effects & Precautions

Erlotinib (brand: Tarceva) is a medication that is generally prescribed for the treatment of:

Non-Small Cell Lung Cancer that has spread to other parts of the body
Advanced Stage Pancreatic Cancer that has spread to other parts of the body along with another medication: Gemcitabine…….

Source: https://rb.gy/angdwy

#Erlotinib #Tarceva #LungCancer #PatientCare #MEDICALADVICE

#Dosage #uses #sideeffects #Treatment #Medication #cancertreatment #LungCancer #PancreaticCancer #EGFRInhibitor #Therapy #Oncology #PrecisionMedicine #DrugInteractions #HealthCare #PatientCare #MEDICALADVICE

Emtricitabine + Tenofovir / Truvada Medication Patient Information in Arabic

Read More: https://www.911globalmeds....

How Tagrisso Osimertinib Medication Can Treat Your lung Cancer?

Tagrisso medication contains an active substance called Osimertinib that belongs to the anti-cancer class of medications known as protein kinase inhibitor.
This substance blocks the mutated receptor in patients who have a T790M mutation to further inhibit the tumor growth.

Source: https://rb.gy/x5pznk

#LungCancerTreatment #TargetedTherapy #HealthCare #HopeForLungCancer #lungcancerawareness

Does Exposure from the Sun Cause Melanoma Skin Cancer

Melanoma Skin Cancer is a type of cancer that forms in the melanocytes – a certain type of skin cell.
A major risk factor of Melanoma is overexposure to the Sun.

Quick facts about Melanoma:

A significant portion of Melanoma cases are diagnosed in women under the age of 40 years.
Melanoma skin cancer can spread to different parts of the body at the early stages as compared to other skin cancer types.
It is recommended to avoid the use of tanning beds as the UV rays from them can destroy skin elasticity and fibres.
.......................
.......................

Read More: https://rb.gy/iouip4

#SunExposureRisk
#melanomaawareness
#skincancerprevention
#SunSafetyTips
#protectyourskin